Slide 1: Pharmaceuticals division
Pharmaceuticals division
Slide 2: Key facts about the pharmacy division. Fiscal year 2023
Key facts about the pharmacy division. Fiscal year 2023 228 1 67 M€ +90% Workforce Factory Sales Export 9% Of total sales 17% Of the workforce Aranjuez (Madrid) 2
Slide 3: Business model
Business model ▪ The activity of the pharmaceuticals division is focused on the production of raw materials and API (Active Pharmaceutical Ingredients), mainly antibiotics. ▪ The division is also specialized in the production of active ingredients and intermediates for third parties, custom designed
Slide 4: Strengths and challenges of the division
Strengths and challenges of the division ▪ The main strengths of this business are: • Mastery of fermentation processes. • Ability to obtain sterile products for injectable use. • High degree of internationalization. • Good positioning as a reliable supplier. ▪ The division's challenges are: • To ma
Slide 5: Diagram of the biological production process
Diagram of the biological production process Raw materials Intermediate processes Final products • Fusidic acid • Sodium fusidate Fusidic Sugar raw Derivatives • Diethanolamine fusidate • Sterile fusidic acid Fermentation Extraction Oil • Ethylsuccinate • Stearate Vegetable Erythromycin Salts • Stol
Slide 6: Diagram of the chemical synthesis production process
Diagram of the chemical synthesis production process Raw materials Intermediate process Final products Fosfomycin calcium Phosphorus trichloride Fosfomycin trometamol Propardylic Sterile alcohol fosfomycin Fosfomycin sodium sodium (injectable) Acid Fosfomycin olefinic PEA salt 6
Slide 7: Products and applications
Products and applications Products Applications Azithromycin Respiratory infections Clarithromycin Respiratory infections Erythromycin and salts Respiratory infections Famotidine Antiulcer Fosfomycin and salt Urinary tract infections Fusidic acid Skin infections Gentamicin Hospital infections Vancom
Slide 8: Markets. Fiscal year 2023
Markets. Fiscal year 2023 Spain 7% Rest of the EU 30% Rest of the world 33% Rest of the OECD 30% 8
Slide 9: Organizational structure
Organizational structure Pharmaceuticals division Commercial Aranjuez Factory Planning and control R&D Quality Human resources and legal advice Prevention and environment 9
Slide 10: Division directory
Division directory Division manager Mª Carmen Cruzado Headquarters and facility Commercial department Paseo del Deleite, s/n Sales director: Oscar Méndez 28300 Aranjuez (Madrid) Tel.: +34 918 090 344 Spain E-mail: farmaciacomercial@ercros.es Tel.: +34 918 090 340 E-mail: aranjuez@ercros.es R+D depar
Slide 11: Main R+D projects
Main R+D projects ▪ Main projects: • New active pharmaceutical ingredients by fermentation. • Expansion of the catalogue of products offered in sterile quality. 11
Slide 12: Accreditations
Accreditations ▪ Prevention management system according to ISO 45001. ▪ Quality management system according to ISO 9001. ▪ Environmental management system according to ISO 14001. ▪ Energy management system according to ISO 50001. ▪ Verification of greenhouse gas (GHG) emissions according to ISO 1406
Slide 13: Sustainability: programs, agreements and ratings
Sustainability: programs, agreements and ratings ▪ Responsible Care: Program of good practices in sustainability of the global chemical sector. ▪ Global Compact: Program promoted by the UN that contains 10 principles of action. ▪ Carbon Disclosure Project (CDP): Organization designed to assess the b
Slide 14: Compliance with the sustainable development goals (SDGs)
Compliance with the sustainable development goals (SDGs) ▪ In the development of its activity, Ercros contributes to the fulfillment of the 17 SDGs established in the UN 2030 Agenda, although it has a special impact on: • SDG 3: Good health and well being. • SDG 6: Clean water and sanitation. • SDG
Slide 15: For more information
For more information Ercros, S.A. Av. Diagonal, 593-595 (+34) 934 393 009 ercros@ercros.es www.ercros.es www.linkedin.com/company/ercros/